Psychiatry
Postpartum Depression
46
Pipeline Programs↗
9
Active Trials↗
23
Companies Involved↗
Postpartum Depression is a moderately active landscape with 46 programs across 23 companies. The most active players are Pragma, Nanjing Minova Pharmaceutical Co., Ltd., Brii Biosciences Limited. 13 therapies are approved with 5 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical13
Phase 11
Phase 214
Phase 35
Analysis
Trial Status
57
clinical trials
Completed33 · 58%
Terminated7 · 12%
Recruiting5 · 9%
Unknown status4 · 7%
Not yet recruiting3 · 5%
Withdrawn3 · 5%
Other2 · 4%
Clinical Trials
Trial Activity
57 trials
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
Recruiting·WWomen's Hospital School Of Medicine Zhejiang University·Phase 4·NCT05826327·364 enrolled
The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
Active, not recruiting·—·Phase 1·NCT04950868·22 enrolled
Quetiapine Versus Trazadone in Women With Postpartum Depression
Not yet recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 1·NCT06546358·50 enrolled
Whole-Body Hyperthermia for Mood and Anxiety Disorders
Not yet recruiting·WWeill Medical College of Cornell University·Preclinical·NCT06144294·240 enrolled
Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine
Completed·—·Phase 3·NCT01527786·25 enrolled
Moringa Oleifera and Phoenix Dactylifera L. Effects on Cortisol and Breast Milk in Postpartum Depression
Completed·—·N/A·NCT07337512·363 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)